{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:59:34Z","timestamp":1792033174677,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,10]]},"DOI":"10.7759\/cureus.64288","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:47:02Z","timestamp":1720676822000},"source":"Crossref","is-referenced-by-count":2,"title":["Pyoderma Gangrenosum: A Presenting Feature of Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Pooja","family":"Chaurasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishtha","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Deokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti S","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayush","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03565.x","article-title":"Rheumatoid neutrophilic dermatitis associated with pyoderma gangrenosum","volume":"142","author":"MacAya A","year":"2000","unstructured":"MacAya A, Servitje O, Jucgl\u00e0 A, Peyr\u00ed J. Rheumatoid neutrophilic dermatitis associated with pyoderma gangrenosum. Br J Dermatol. 2000, 142:1246-8. 10.1046\/j.1365-2133.2000.03565.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum","volume":"13","author":"Ahronowitz I","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum. Am J Clin Dermatol. 2012, 13:191-211. 10.2165\/11595240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus AM","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011, 165:1244-50. 10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0092-6","article-title":"Neutrophilic dermatoses: an update","volume":"15","author":"Alavi A","year":"2014","unstructured":"Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update. Am J Clin Dermatol. 2014, 15:413-22. 10.1007\/s40257-014-0092-6","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese CA","year":"2022","unstructured":"Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol. 2022, 23:615-34. 10.1007\/s40257-022-00699-8","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen JP","year":"2007","unstructured":"Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007, 33:787-802, vi. 10.1016\/j.rdc.2007.07.016","journal-title":"Rheum Dis Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.12.1546","article-title":"Clinical features and treatment of peristomal pyoderma gangrenosum","volume":"284","author":"Hughes AP","year":"2000","unstructured":"Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA. 2000, 284:1546-8. 10.1001\/jama.284.12.1546","journal-title":"JAMA"},{"key":"ref8","article-title":"Pyoderma gangrenosum - clinical, laboratory and therapeutic approaches. Review of 28 cases [Article in Portuguese]","volume":"15","author":"Duarte AF","year":"2009","unstructured":"Duarte AF, Nogueira A, Lisboa C, Azevedo F. Pyoderma gangrenosum - clinical, laboratory and therapeutic approaches. Review of 28 cases [Article in Portuguese]. Dermatol Online J. 2009, 15:3.","journal-title":"Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2013.02.004","article-title":"Pyoderma gangrenosum associated with rheumatoid arthritis: a case report [Article in Portuguese]","volume":"54","author":"Beber AA","year":"2014","unstructured":"Beber AA, Knob CF, Shons KR, Neumaier W, da Silva JC, Monticielo OA. Pyoderma gangrenosum associated with rheumatoid arthritis: a case report [Article in Portuguese]. Rev Bras Reumatol. 2014, 54:322-5. 10.1016\/j.rbr.2013.02.004","journal-title":"Rev Bras Reumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5499\/wjr.v5.i2.101","article-title":"Pyoderma gangrenosum: an important dermatologic condition occasionally associated with rheumatic diseases","volume":"5","author":"Yamamoto T","year":"2015","unstructured":"Yamamoto T. Pyoderma gangrenosum: an important dermatologic condition occasionally associated with rheumatic diseases. World J Rheumatol. 2015, 5:101-7. 10.5499\/wjr.v5.i2.101","journal-title":"World J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/j4030028","article-title":"Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management","volume":"4","author":"Skopis M","year":"2021","unstructured":"Skopis M, Bag-Ozbek A. Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management. J. 2021, 4:367-75. 10.3390\/j4030028","journal-title":"J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum - a guide to diagnosis and management","volume":"19","author":"George C","year":"2019","unstructured":"George C, Deroide F, Rustin M. Pyoderma gangrenosum - a guide to diagnosis and management. Clin Med (Lond). 2019, 19:224-8. 10.7861\/clinmedicine.19-3-224","journal-title":"Clin Med (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi Y","year":"1998","unstructured":"Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF 3rd, Petty HR. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol. 1998, 111:259-68. 10.1046\/j.1523-1747.1998.00311.x","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2762-2","article-title":"Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease","volume":"58","author":"Arg\u00fcelles-Arias F","year":"2013","unstructured":"Arg\u00fcelles-Arias F, Castro-Laria L, Lobat\u00f3n T, et al.. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci. 2013, 58:2949-54. 10.1007\/s10620-013-2762-2","journal-title":"Dig Dis Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15850","article-title":"Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series","volume":"178","author":"Song H","year":"2018","unstructured":"Song H, Lahood N, Mostaghimi A. Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series. Br J Dermatol. 2018, 178:363-8. 10.1111\/bjd.15850","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269386-pyoderma-gangrenosum-a-presenting-feature-of-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:47:05Z","timestamp":1720676825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269386-pyoderma-gangrenosum-a-presenting-feature-of-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.64288","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}